STD LF ABERDEEN/ADR (OTCMKTS:SLFPY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports.

According to Zacks, “Standard Life plc provides asset management and long-term savings solutions. The company’s product and service includes pensions, individual savings accounts, investment bonds and mutual funds. It also offers life assurance, investment trust, wealth management and support services. Standard Life plc is headquartered in Edinburgh, the United Kingdom. “

SLFPY has been the topic of several other reports. ValuEngine upgraded STD LF ABERDEEN/ADR from a “sell” rating to a “hold” rating in a report on Tuesday, June 23rd. Credit Suisse Group lowered STD LF ABERDEEN/ADR from a “neutral” rating to an “underperform” rating in a research report on Wednesday, April 8th.

Shares of OTCMKTS:SLFPY traded down $0.03 during trading on Tuesday, reaching $13.10. 109 shares of the company traded hands, compared to its average volume of 430. The company’s 50 day moving average is $12.36 and its two-hundred day moving average is $13.51. STD LF ABERDEEN/ADR has a 52 week low of $7.68 and a 52 week high of $17.46.

STD LF ABERDEEN/ADR Company Profile

Standard Life Aberdeen plc provides asset management services in the United Kingdom, Europe, North America, and Asia. The company offers investment solutions and funds; long-term savings and investment products to individual and corporate customers; and life insurance and savings products. It provides its products through institutional, wholesale, and retail distribution channels.

Recommended Story: Initial Coin Offerings entail a high degree of risk

Get a free copy of the Zacks research report on STD LF ABERDEEN/ADR (SLFPY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for STD LF ABERDEEN/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STD LF ABERDEEN/ADR and related companies with MarketBeat.com's FREE daily email newsletter.